Logo image of NUTR

NUSATRIP INC (NUTR) Stock Fundamental Analysis

USA - NASDAQ:NUTR - US67119K1025 - Common Stock

6.89 USD
+0.68 (+10.95%)
Last: 9/25/2025, 7:45:12 PM
6.5013 USD
-0.39 (-5.64%)
After Hours: 9/25/2025, 7:45:12 PM
Fundamental Rating

3

Taking everything into account, NUTR scores 3 out of 10 in our fundamental rating. NUTR was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. While NUTR seems to be doing ok healthwise, there are quite some concerns on its profitability. NUTR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NUTR had negative earnings in the past year.
NUTR had a positive operating cash flow in the past year.
NUTR Yearly Net Income VS EBIT VS OCF VS FCFNUTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 500K -500K -1M -1.5M

1.2 Ratios

NUTR has a Return On Assets of 1.54%. This is comparable to the rest of the industry: NUTR outperforms 42.54% of its industry peers.
Industry RankSector Rank
ROA 1.54%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUTR Yearly ROA, ROE, ROICNUTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 10 -10 20 30

1.3 Margins

With a Profit Margin value of 3.43%, NUTR perfoms like the industry average, outperforming 49.25% of the companies in the same industry.
NUTR's Gross Margin of 98.15% is amongst the best of the industry. NUTR outperforms 99.25% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 3.43%
GM 98.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NUTR Yearly Profit, Operating, Gross MarginsNUTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 50 -50 -100

5

2. Health

2.1 Basic Checks

NUTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
NUTR has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for NUTR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NUTR Yearly Shares OutstandingNUTR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
NUTR Yearly Total Debt VS Total AssetsNUTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 1M 2M 3M 4M

2.2 Solvency

An Altman-Z score of 5.23 indicates that NUTR is not in any danger for bankruptcy at the moment.
The Altman-Z score of NUTR (5.23) is better than 85.07% of its industry peers.
There is no outstanding debt for NUTR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Altman-Z 5.23
ROIC/WACCN/A
WACC10.45%
NUTR Yearly LT Debt VS Equity VS FCFNUTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 -1M -2M -3M

2.3 Liquidity

NUTR has a Current Ratio of 0.43. This is a bad value and indicates that NUTR is not financially healthy enough and could expect problems in meeting its short term obligations.
NUTR has a worse Current ratio (0.43) than 81.34% of its industry peers.
A Quick Ratio of 0.41 indicates that NUTR may have some problems paying its short term obligations.
With a Quick ratio value of 0.41, NUTR is not doing good in the industry: 78.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.41
NUTR Yearly Current Assets VS Current LiabilitesNUTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2M 4M 6M 8M

2

3. Growth

3.1 Past

NUTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.31%, which is quite impressive.
The Revenue has grown by 64.34% in the past year. This is a very strong growth!
EPS 1Y (TTM)110.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.79%
Revenue 1Y (TTM)64.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUTR Yearly Revenue VS EstimatesNUTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 500K 1M 1.5M 2M

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NUTR Price Earnings VS Forward Price EarningsNUTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NUTR is valued expensively inside the industry as 83.58% of the companies are valued cheaper.
NUTR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 46.11
EV/EBITDA 2478.37
NUTR Per share dataNUTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NUTR!.
Industry RankSector Rank
Dividend Yield N/A

NUSATRIP INC

NASDAQ:NUTR (9/25/2025, 7:45:12 PM)

After market: 6.5013 -0.39 (-5.64%)

6.89

+0.68 (+10.95%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap133.53M
AnalystsN/A
Price TargetN/A
Short Float %10.85%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 57.86
P/FCF 46.11
P/OCF 45.72
P/B N/A
P/tB N/A
EV/EBITDA 2478.37
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY2.17%
OCF(TTM)0.15
OCFY2.19%
SpS0.12
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.43%
GM 98.15%
FCFM 125.5%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 21.85%
Cap/Sales 1.07%
Interest Coverage N/A
Cash Conversion 6187.71%
Profit Quality 3661.31%
Current Ratio 0.43
Quick Ratio 0.41
Altman-Z 5.23
F-Score7
WACC10.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)64.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y96.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-244.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-203.83%
OCF growth 3YN/A
OCF growth 5YN/A